Capper, David <br/><br/>
Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes.  [electronic resource] 

 -  The American journal of surgical pathology  Aug 2010 
 - 1199-204 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-0979 
<br/><br/><label>Standard No.: </label>10.1097/PAS.0b013e3181e7740d  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibody Specificity<br/>Biomarkers, Tumor--analysis<br/>Biopsy<br/>Brain Neoplasms--enzymology<br/>Diagnosis, Differential<br/>Glioma--enzymology<br/>Gliosis--diagnosis<br/>Humans<br/>Immunohistochemistry<br/>Isocitrate Dehydrogenase--analysis<br/>Mutation<br/>Neoplasm Staging<br/>Neuroglia--enzymology<br/>Predictive Value of Tests<br/>Sensitivity and Specificity<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--analysis<br/>WT1 Proteins--analysis